@kopicpeng the best advice anyone should give you is to always set a cut loss no matter what stocks you're buying. no one can tell you how high or how low it will end up. if you scroll up you will see one or two comments boasting about how much he/she has earned and then giving nonsensical comments but again there are suckers like this at possibly any counter. There are many good stocks to look at, so set your own cut loss and ride with the flow.

@dongbei if you don't mind me saying this, you just need a reasonable level of respect for trading/finance houses and not too much of it. Somehow you need to make your own judgements and evaluations v your risk appetite. There are over a thousand counters in KLSE and plenty of terrible valuations are made each day by these trading houses. Just speaking the truth.

Record high net profit possible to see this stock run up to 80cents at least?

(partial of my two cents in reply to fungau)

As the first Malaysian-owned freight service company to be listed on the Main Board of Bursa, FREIGHT has proven its resilience throughout this entire period of time. While we expect many industries to suffer from continuous lockdowns and restrictions, Freight has still managed to clock over 20mil in Profit before Tax (end 2020). On top of this we see an increase in Net Assets per Share from RM0.80 to RM1.04 (from 2016 to 2020) with a healthy cash balance of RM58mil against total borrowing of RM88.5mil (translating to a low net gearing of 0.1x - impressively low for a same-industry comparison).

Breakdown of revenue contribution by service type: land & sea freight, air freight, warehousing and logistics ; the most important to note is segmental contribution by country being Malaysia (74.7%) therefore international closures and restrictions do not severely impact revenue and bottom lines.

Increasing administrative expenses are not always viewed negatively so long as there is a valid reason for it and at the end of it if bottom lines (profit) are protected. Recent information everyone should know by now - increased freight rates v deficit of containers; this doesn't entirely harm the company if cleverly managed, we forget that many times additional costs are pushed to end consumers.

Amputation of loss making tug business arm - we should respect Freight more than being happy for them, no business should continue running a division on losses; it's not about the service itself but perhaps they are better off focusing on their core competencies. (a comparison of "management decisions" can be done with PosM if you bother to do so)

Warehousing & logistics is the past, present and future. What we're all in right now is a pandemic-induced economic and political instability; and this is the 2nd driving force on top of global eCommerce boom for the logistics sector to thrive (if they prove to be worthy). Distribution of vaccines is peanuts if you're geared up and ready to serve the online marketplace directly or indirectly.

Note: much important statistics and figures are obtained directly from Freight's AR 2020 while the rest are personal opinions and in no way intended to harm anyone else. Just to share, I was locked onto Tasco back when they were trading at 80+ cents; also another much respected company in the market. Always happy to see well managed companies doing well.

there is no need to curse anyone. everyone's risk appetite is different. and besides it's still early in the morning. bigger volume transactions will come in the afternoon as usual.

more like 2.40 and beyond for a hot stock.

@Dragon88 down 0.02 cents (barely half a %) is a "drop a lot" to you ?

50% of investing is basic on simple logic. Investing in a business that will still be required whether there is a lockdown or not can never go too wrong. Look at where Tasco was and where they're at now.

@topcat2020 ok thank you for clarifying. Well i guess the lm up cant be controlled for those who are familiar with this counter. Will be interesting to see if esceram will revisit its previous all time high or even surpass it; ruberex broke their record this week. =)

just a personal sharing here. those who were entitled for the bonus share issue and actually sold them off this morning has made the biggest mistake.

i experienced this just last night v this morning (9AM) with Opensys.

In summary: as an example if you had bought 10k units of Esceram yesterday at an avg of RM1.38, your system would show a massive loss this morning at opening because the price adjustment has taken place. However in actual fact you are not making a loss because on the ex-date you will receive your bonus shares and the total worth will equal to the amount as and when you originally bought the shares. (your profit and loss will of course be determined by on-going trading which is happening simultaneously).

In other words, for those who did not sell will see that their units on hand will double up on the ex-date which i believe will be by 5pm tomorrow 15th october or the next day at 9am. And supposedly if the share price tomorrow continues to go up, you will see the full gain (which is a lot) when your account receives the bonus shares.

i cannot say the same for those who have sold theirs before the ex-date because i didn't sell mine (opensys).

so generally speaking esceram had become a huge bargain stock this morning; because it's price has been adjusted down, holders of the stock benefit greatly and also allows for new investors to sweep it at a bargain price. for those who are still holding it and was entitled to the bonus issue, don't be shocked when a huge gain is reflected on your account.

as for exact calculation i'm unable to give an answer because after the price adjustment (my case of opensys) i actually bought more of it at the adjusted price.

anyone can correct me if im wrong but i did have first hand experience this morning.

today is not a limit up (at closing it is up 29.5 cents with open sellers at RM 0.825

too many good reasons to buy and hold Scomnet:

- a cash rich company with zero borrowings
- strong and reliable management
- forward moving core business that constantly develops solutions for market requirements
- constant upward moving revenue + profit margin
- strong ties with international markets

really looking forward to their next qtr report. RM2 will be history very soon imo.

Esceram is the only counter left that is directly benefiting from exponential glove production and the only counter left that is now below rm1. Tomorrow onwards it will only push upwards regardless of any profit taking.

Newcomers, if your system enables you to view the buy and sell movement please go and see the massive buys before 5pm closing.

If you make rash decisions you will get burnt. I feel bad for all those who entered high and sold on panic. The real sharks are those who profit on high volatily times of the day, not only once but twice or 3 times a day.

because they're not Robert Kuok =.=

haha guys just ignore secretinvestor. been watching his posts he goes around to every performing counter to say something like that. probably got some mental issues. dont get so worked up by him.

@gemstar as i mentioned before, Scomnet has never lagged. it doesn't and shouldn't be grouped together with the other health counters.

@gohku fyi their core business isnt fully in healthcare. their specialty cable business is steady and strong as well.

@lancefire in agreement with you that Scomnet is fundamentally strong.

contra players dont bother playing this counter if you don't even bother to find out Cypark's core business and look at some super basic information. steady revenue with good profit margin and results what else do you need to convince yourself while selecting counters to invest. low to high gearing doesn't mean nuts if you don't even bother to look at what they do.

There's no reason to panic now. KLCI has been performing best amongst asian countries. there's bound to be up and downs. today is red across all markets. no big deal

it's world wide index down guys. not just any health counters. go and have a look.

hi everyone. i think it's important to note that Scomnet did not only produce a successful product for Covid treatment. Their core business is also in electrical and electronic cables; an industry that is poised to prosper. Nevertheless their disposable medical consumables will be the main driver this year for their huge growth and earnings.

Initiative to boost auto market + reopening of domestic flights = double win for umw this month

China was never in the picture for Ocncash's business when it comes to revenue. There are so many countries to serve.

Governments initiative to boost auto sales + nonwoven felt for the medical industry = double win for ocncash. Hold for long bull run.

news says they're "eye-ing the glove market". they do not manufacture gloves yet and probably wont be able to do so in the next few years.

Guys, look at the core business and then look at value of share price. UMW is worth a lot more and their good reputation precedes all. Buy to keep.

*if i'm wrong.

Ocncash would be a better choice than this if you're looking for non-woven felt suppliers used directly for covid-19 measures. For TekSeng the % of core business serving the medical industry is extremely low, someone may correct me im wrong.

@engineeringprofit you might as well say closing 7.00 haha

New outbreak. Ebola in Congo. Yet another driver for continuous rally.

@gemfinder u dont bother to even find out what counter this is and u're saying becareful.

not this week show time. is tomorrow show time.

if you think that careplus is going to limit down tomorrow you're probably living in your dreams. corrections will always be due and when all the small contra players take profit there will be many waiting to snap it up. cheers and happy sunday.

latest news: south korea closed schools again cases spike up. prevention and action = gloves gloves gloves. wish i can make my own gloves.

congrats again to those who made some good earnings. for those still holding please don't every single day wish to limit up limit up. next week will up + some corrections no need to fret too much.

Happy trading guys. Tp 1.5 to 2.00 easily soon. Those who take profit good for you. Those who hold long long also good for you. Next week when more construction companies start posting negative results you will see more daily volumes coming in. Cheers.

@sapodilla so you believe that during the start of the epidemic the group management will sell of their glove making arm for the mere purpose of retaining 17mil ? If that is the sole purpose of a jv it would be quite shallow thinking. Cheers.

my 2 cents why there shouldn't be any worry on health or glove counters in general vs market movements this week:
1. the US-China trade tension is back and higher than before (which i feel malaysia could benefit from indirectly)
2. HKSE is at its worst (not forgetting pre-covid economic meltdown + new post-covid political instability)
3. US currency against MYR is still somewhat volatile which indirectly reflects on operating margins and/or forex issues for Malaysian companies.

my point is there are too many factors why there isn't much movement especially today. nothing wrong with it. bursa investors being cautious isn't always a bad thing. as long as the health/glove counters manages their business competently we should be expecting some healthy positive qr results coming up.

@geco i re-read to the bottom and it seems yes it is on fda listing. Thank you for pointing that out to me. However as i am involved directly in a business myself, i think im compelled to point out that every product coming across a hiccup deserves time to sort out even if it is just paperworks. I also believe that it is only right if the fda conforms to its safety guideline to keep things in check. I'm not here to join any arguments between some people who seem to me like little children with some money to play around with. I do hold a few shares of comfort where its amount may be laughable by some people. I can only trust my judgement on financial releases. Other than that i hope im ok.

I feel sorry for investors who are unable to read and understand foreign reports. The fda report clearly does not mention comfort or any other glove makers in specific, rather it is a warning to its own field agents as it should be.

New investors, kindly at least know how to look at simple financial results and you will see that comfort is not a joke. If you buy or sell listening to people posting fake and old news entirely, then please dont invest in stocks. Put your money in the bank fixed deposit and be happy with it.

Happy trading. :)

please stop shouting gap up. no need to shout also tomorrow will gap up.

@JT5774 i however have a higher TP than yours.

@JT5774 i agree with you and also spoke about this earlier.

i do however feel sorry for those who keeps thinking a possibility of vaccine has got anything to do with glove makers' performance this year specifically.

@goldbabymilk i would advise not to buy or sell anything on peak hours/minutes on rakuten. they're trying to fix their site will take some time. making moves at 9am and 2.30pm is going to cost you.

sorry guys my interpretation could have come out misunderstood. I personally don't par a company's performance directly point on point against it's competitor especially when it comes to a global market. each company in its' industry will fare different from another for many many reasons.

i do agree with above that don't expect too much or don't expect the same results with the big four. i assess a company individually and its' potential for growth and success at its own pace. i also don't invest in companies merely on their past. the current and future is most often more important. people keep talking about vaccines for covid and the reality of that is far beyond reach. what's real now is that ppe / medical equipments / gloves are being transported daily across the globe like a commodity itself. Even logistic companies who are able to capitalize on this can benefit rather than a sitting duck with no business to run.

there is also no wrong or right when it comes to disposal of shares. major corporations have to sell because they're holding too much devalued stocks in other industries in order to cover losses. i see it as a strength, not a weakness. retail investors may also sell to make quick profits. nothing wrong as well. just dont forget, there's a pool of investors just parking there and letting it grow.

the US-China trade war is continuing and will get worse. Malaysia has much to benefit from this.

if you find the medical industry totally illegitimate, go and find yourself another industry that can possibly perform this year (if not politically influenced).

There is little reason to have to keep convincing investors on major growth and earning prospects of glove makers. Those who think a vaccine is going to be successful now is just naive. Numbers of covid cases speak for themselves. All glove makers will be running at max capacity this year. Results will show by itself. Careplus will take time to turnaround with the JV but i'm very sure they will return to the black this year.

@donald770
Very true.

As for other holders of Scomnet, don't let figures from other counters affect you. Every counter has got it's own pace. Hold tight to this and watch it grow steadily as it should.

@donald770

i do agree that collection is indeed and has already happened for this stock. I have been observing for 3 consecutive days that while some are selling, many should be collecting. Scomnet's recent disposable bronchoscope which has full approval from US authorities will be the catalyst for their tremendous growth not only in terms of monetized financial quarters but also opens them up to many opportunities in the medical industry. Scomnet is a company not to be missed for mid to long term investments.

just in: Single Tier Interim Dividend of 2 sen to be determined ex date 5th June 2020. =)

hi guys, if you're really that interested take some time to look into their annual report to understand their actual core business. this is going to be a great financial year for Adventa due to their services in the healthcare sector.